Fig. 2
From: Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions
Primary cholangiocarcinoma and metastatic pancreatic ductal adenocarcinoma. a. Primary cholangiocarcinoma (HE, 100x); b. CD34 expression in cholangiocarcinoma (CD34, 200x); c. PSMA peritumoral/vascular expression in cholangiocarcinoma (PSMA, 200x). d. Metastatic pancreatic ductal adenocarcinoma in liver (HE, 100x) e. CD34 expression in pancreatic ductal adenocarcinoma (CD34, 200x); f. PSMA is negative in metastatic pancreatic ductal adenocarcinoma (PSMA, 200x)